MMX
LIVE

Serial Number

88820915

Owner

Cosmo Technologies Ltd

Attorney

John Pickerill

Filing Date

Mar 4, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MMX Trademark

Serial Number: 88820915 • Registration: 6481563

MMX is a trademark filed by Cosmo Technologies Ltd on March 4, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cosmo Technologies Ltd (23 trademarks)

Riverside II
Dublin 2 , IE

Entity Type: 99

Trademark Details

Filing Date

March 4, 2020

Registration Date

September 14, 2021

Published for Opposition

June 29, 2021

Goods & Services

Contrast media for use with medical equipment or in medical imaging, namely, endoscopy, x-ray, ultrasound, MRI, PET and CT equipment; Diagnostic agents and reagents for medical use; Diagnostic preparations for medical purposes; Pharmaceutical preparations and substances, namely, prescription medicines in the form of pills, tablets, capsules, caplets, and liquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders, gastrointestinal diseases or digestive system disorders; Pharmaceutical preparations for the treatment or prevention of IBS (irritable bowel syndrome); Non-prescription medicines, namely, pills, tablets, capsules, caplets, and liquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with gastroscopic, endoscopic, colonoscopic, sigmoidoscopic, anoscopic, rectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detection, diagnosis, prevention or treatment of gastroenterological diseases; pharmaceutical preparations for use in gastroenterology, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceutical, medical and surgical purposes, namely, detection, diagnosis, prevention or treatment of gastroenterological diseases; Medical and surgical dyes, namely, methylene blue dye; Medical dyes for pharmaceutical and diagnostic purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations for the diagnosis, prevention or treatment of ulcerative colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertility, reproductive health, hematology, urology, gynecology, obstetrics, endocrinology, oncology, renalology, immunology and inflammatory diseases, disorders and conditions; pharmaceutical preparations for colon and digestive system health and regulation, for improving energy levels or for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; Anti-nausea medication; antiemetic preparations; antibiotic preparations; pharmaceutical preparations for the treatment or prevention of travelers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis

Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Filing History

REGISTERED-PRINCIPAL REGISTER
Sep 14, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 29, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 29, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 9, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 7, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 19, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 19, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 19, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2021 CRFA
ASSIGNED TO LIE
Mar 10, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Dec 8, 2020 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 7, 2020 TROA
PETITION TO REVIVE-GRANTED
Dec 7, 2020 PETG
TEAS PETITION TO REVIVE RECEIVED
Dec 7, 2020 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 4, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 4, 2020 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 19, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2020 REAP
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Nov 17, 2020 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 17, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2020 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2020 CNRT
ASSIGNED TO EXAMINER
May 20, 2020 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 11, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 11, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 11, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 11, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 11, 2020 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2020 NWOS
NEW APPLICATION ENTERED
Mar 7, 2020 NWAP